Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA02 - Improving Outcomes for Patients with Lung Cancer
- 10:30 - 12:00
- 9/24/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA02.01 - ROS1 Gene Rearrangements Are Associated with an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events
10:30 - 10:35 | Presenter: Terry L. Ng | Author(s): Derek E Smith, Rao Mushtaq, Tejas Patil, Anastasios Dimou, Shuo Yang, Qian Liu, Xuefei Li, Caicun Zhou, Flora Yan, I. Alex Bowman, Stephen V Liu, Robert C. Doebele, Dara L. Aisner, Shengxiang Ren, Ross Camidge
- Abstract
Loading...
-
+
MA06 - PDL1, TMB and DNA Repair
- 13:30 - 15:00
- 9/24/2018
- Location: Room 206 AC
- Type: Mini Oral Abstract Session
- Track: Biology
-
+
MA06.11 - Distinct Origins of Lymphatic and Brain Metastasis in Lung Cancer
14:40 - 14:45 | Presenter: Tao Jiang | Author(s): Yan Yan, Caicun Zhou
- Abstract
Loading...
-
+
MA09 - Lung Cancer Surgical and Molecular Pathology
- 15:15 - 16:45
- 9/24/2018
- Location: Room 202 BD
- Type: Mini Oral Abstract Session
- Track: Pathology
-
+
MA09.11 - Genomic Landscape and its Correlation with TMB, CD8 TILs and PD-L1 Expression in Chinese Lung Squamous Cell Carcinoma
16:25 - 16:30 | Presenter: Tao Jiang | Author(s): Jinpeng Shi, Chunyan Wu, Henghui Zhang, Caicun Zhou
- Abstract
Loading...
-
+
OA07 - Oligometastasis: What Should Be the State-Of-The-Art?
- 15:15 - 16:45
- 9/24/2018
- Location: Room 107
- Type: Oral Abstract Session
- Track: Oligometastatic NSCLC
-
+
OA07.03 - Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC pts with Oligometastatic or Oligoprogressive Liver Metastases
15:35 - 15:45 | Presenter: Tao Jiang | Author(s): Caicun Zhou, Huijuan Wang, Qian Chu
- Abstract
Loading... -
+
OA07.05 - Local Ablative Therapy Improves Survival in Patients with Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated with EGFR-TKIs
16:00 - 16:10 | Presenter: Yaping Xu | Author(s): Qinghua Xu, Fei Zhou, Hui Liu, Caicun Zhou
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-111 - EGFR exon20 Insertion Patients Treated with First-Line Chemotherapy in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Chao Zhao | Author(s): Xuefei Li, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P1.01-112 - Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC
16:45 - 18:00 | Presenter: Caicun Zhou | Author(s): Ying Cheng, Yong He, Wei Li, Helong Zhang, Qing Zhou, Buhai Wang, Chunling Liu, Suresh S. Ramalingam, Andrew Walding, Matilde Saggese, Jia Wang, Minhao Fan, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-98 - A Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions
16:45 - 18:00 | Presenter: Yi-Long Wu | Author(s): Haiyan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Kai Li, Yi Ping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, BJ Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Dennis Chin-Lun Huang, Yu Wang, Kaimin Pang, Caicun Zhou
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-26 - First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant Nsclc Patients with Oligoprogressive Disease
16:45 - 18:00 | Presenter: Qinghua Xu | Author(s): Hui Liu, Tao Jiang, Shengxiang Ren, Caicun Zhou
- Abstract
Loading...
-
+
MA11 - Biomarkers of IO Response
- 10:30 - 12:00
- 9/25/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA11.11 - Discrepancy of Tumor Neoantigen Burden Between Primary Lesions and Matched Metastases in Lung Cancer
11:40 - 11:45 | Presenter: Tao Jiang | Author(s): Caicun Zhou
- Abstract
Loading...
-
+
OA10 - Right Patient, Right Target & Right Drug - Novel Treatments and Research Partnerships
- 10:30 - 12:00
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA10.07 - Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer Patients: Analysis from AURA17 Trial
11:35 - 11:45 | Presenter: Caicun Zhou | Author(s): Min Hu, Xuehua Zhu, Yun Sun, Xuesong Lu, Jia Wang, Mengzhao Wang, Ying Cheng, Yuan Chen, Yanqiu Zhao, Yuan-Kai Shi, You Lu, Meiqi Shi, He-Long Zhang, Xiangning Huang, Zheng Wang, Zhijie Ding, Heyan Li, George Chen, Yi-Long Wu
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.09 - Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated with First-Line EGFR-TKIs
14:30 - 14:35 | Presenter: Chunxia Su | Author(s): Tao Jiang, Jing Zhao, Xuefei Li, Caicun Zhou
- Abstract
Loading... -
+
MA15.10 - Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
14:35 - 14:40 | Presenter: Sha Zhao | Author(s): Tao Jiang, Xuefei Li, Chao Zhao, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading...
-
+
P2.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.04-13 - The Immune Checkpoint, HVEM Contribute to Immune Escape in Non Small Cell Lung Cancer of Lacking PDL1 Expression
16:45 - 18:00 | Presenter: Shengxiang Ren | Author(s): Hui Yu, Christopher J. Rivard, Kenichi Suda, Charles Caldwell Jr, Leslie Rozeboom, Terry L. Ng, Gareth Rivalland, Paul Mitchell, Caicun Zhou, Fred R. Hirsch
- Abstract
Loading...